Toyota|$17.91 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.07 (¥3,960)+0.00%▲ (in JPY terms)
SoftBank|$28.83 (¥4,554)-6.01%▼ (in JPY terms)
MUFG|$21.22 (¥3,351)-3.65%▼ (in JPY terms)
Keyence|$512.29 (¥80,910)-0.61%▼ (in JPY terms)
Nintendo|$54.96 (¥8,680)+1.63%▲ (in JPY terms)
NTT|$1.12 (¥177)+1.14%▲ (in JPY terms)
Takeda|$39.95 (¥6,310)+1.06%▲ (in JPY terms)
Tokyo Electron|$63.85 (¥10,085)-2.56%▼ (in JPY terms)
Recruit|$119.03 (¥18,800)+0.13%▲ (in JPY terms)
ITOCHU|$14.55 (¥2,298)-0.95%▼ (in JPY terms)
Honda|$11.42 (¥1,804)-0.19%▼ (in JPY terms)
Shin-Etsu|$37.16 (¥5,869)-1.63%▼ (in JPY terms)
Tokio Marine|$3.45 (¥544)-1.91%▼ (in JPY terms)
Fast Retailing|$477.15 (¥75,360)+2.04%▲ (in JPY terms)
Toyota|$17.91 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.07 (¥3,960)+0.00%▲ (in JPY terms)
SoftBank|$28.83 (¥4,554)-6.01%▼ (in JPY terms)
MUFG|$21.22 (¥3,351)-3.65%▼ (in JPY terms)
Keyence|$512.29 (¥80,910)-0.61%▼ (in JPY terms)
Nintendo|$54.96 (¥8,680)+1.63%▲ (in JPY terms)
NTT|$1.12 (¥177)+1.14%▲ (in JPY terms)
Takeda|$39.95 (¥6,310)+1.06%▲ (in JPY terms)
Tokyo Electron|$63.85 (¥10,085)-2.56%▼ (in JPY terms)
Recruit|$119.03 (¥18,800)+0.13%▲ (in JPY terms)
ITOCHU|$14.55 (¥2,298)-0.95%▼ (in JPY terms)
Honda|$11.42 (¥1,804)-0.19%▼ (in JPY terms)
Shin-Etsu|$37.16 (¥5,869)-1.63%▼ (in JPY terms)
Tokio Marine|$3.45 (¥544)-1.91%▼ (in JPY terms)
Fast Retailing|$477.15 (¥75,360)+2.04%▲ (in JPY terms)

2026-03-23 Eisai Co.,Ltd. “Analysis results on the long-term treatment continuation of "Rekenbi®" (lecanemab) in real-world clinical practice in the United States were presented at AD/PD™ 2026—analysis of "Rekenbi" real-world clinical data revealed the patient's choice to continue long-term treatment.”

by

2026-03-23 Eisai Co.,Ltd. “Analysis results on the long-term treatment continuation of "Rekenbi®" (lecanemab) in real-world clinical practice in the United States were presented at AD/PD™ 2026—analysis of "Rekenbi" real-world clinical data revealed the patient's choice to continue long-term treatment.”

Tags: Eisai Co.,Ltd.JP3160400002

コメントする

Contact